The global Injectable Viscosupplementation market was valued at US$ 1822 million in 2023 and is anticipated to reach US$ 2329.4 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.

Injectable Viscosupplementation Market

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis. Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful. Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.

Viscosupplementation involves the injection of hyaluronic acid-based solutions into the joints to relieve pain and improve mobility in patients with osteoarthritis. Factors driving market growth include the increasing prevalence of osteoarthritis, growing aging population, and the effectiveness of viscosupplementation in managing symptoms. The market is highly competitive, with several manufacturers offering viscosupplementation devices. However, challenges such as limited insurance coverage, high treatment costs, and the availability of alternative therapies may hinder market expansion. Nonetheless, the viscosupplementation devices market holds promising opportunities, driven by the rising demand for non-surgical treatment options for osteoarthritis and ongoing research and development efforts to enhance the efficacy of viscosupplementation products.

This report aims to provide a comprehensive presentation of the global market for Injectable Viscosupplementation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Viscosupplementation.

Report Scope

The Injectable Viscosupplementation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Viscosupplementation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Injectable Viscosupplementation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Injectable Viscosupplementation Market Report

Report Metric	Details
Report Name	Injectable Viscosupplementation Market
Accounted market size in 2023	US$ 1822 million
Forecasted market size in 2030	US$ 2329.4 million
CAGR	3.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Single Injection Three Injection Five Injection
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi, Anika Therapeutics, Seikagaku, Zimmer Biomet, Bioventus, Ferring, LG Chem, Freda, Haohai Biological, Shanghai Jingfeng
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Viscosupplementation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Viscosupplementation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Injectable Viscosupplementation Market growing?

Ans: The Injectable Viscosupplementation Market witnessing a CAGR of 3.6% during the forecast period 2024-2030.

What is the Injectable Viscosupplementation Market size in 2030?

Ans: The Injectable Viscosupplementation Market size in 2030 will be US$ 2329.4 million.

Who are the main players in the Injectable Viscosupplementation Market report?

Ans: The main players in the Injectable Viscosupplementation Market are Sanofi, Anika Therapeutics, Seikagaku, Zimmer Biomet, Bioventus, Ferring, LG Chem, Freda, Haohai Biological, Shanghai Jingfeng

What are the Application segmentation covered in the Injectable Viscosupplementation Market report?

Ans: The Applications covered in the Injectable Viscosupplementation Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Injectable Viscosupplementation Market report?

Ans: The Types covered in the Injectable Viscosupplementation Market report are Single Injection, Three Injection, Five Injection

1 Injectable Viscosupplementation Market Overview

1.1 Product Overview and Scope of Injectable Viscosupplementation

1.2 Injectable Viscosupplementation Segment by Type

1.2.1 Global Injectable Viscosupplementation Market Value Comparison by Type (2024-2030)

1.2.2 Single Injection

1.2.3 Three Injection

1.2.4 Five Injection

1.3 Injectable Viscosupplementation Segment by Application

1.3.1 Global Injectable Viscosupplementation Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Injectable Viscosupplementation Market Size Estimates and Forecasts

1.4.1 Global Injectable Viscosupplementation Revenue 2019-2030

1.4.2 Global Injectable Viscosupplementation Sales 2019-2030

1.4.3 Global Injectable Viscosupplementation Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Injectable Viscosupplementation Market Competition by Manufacturers

2.1 Global Injectable Viscosupplementation Sales Market Share by Manufacturers (2019-2024)

2.2 Global Injectable Viscosupplementation Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Injectable Viscosupplementation Average Price by Manufacturers (2019-2024)

2.4 Global Injectable Viscosupplementation Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Injectable Viscosupplementation, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Injectable Viscosupplementation, Product Type & Application

2.7 Injectable Viscosupplementation Market Competitive Situation and Trends

2.7.1 Injectable Viscosupplementation Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Injectable Viscosupplementation Players Market Share by Revenue

2.7.3 Global Injectable Viscosupplementation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Injectable Viscosupplementation Retrospective Market Scenario by Region

3.1 Global Injectable Viscosupplementation Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Injectable Viscosupplementation Global Injectable Viscosupplementation Sales by Region: 2019-2030

3.2.1 Global Injectable Viscosupplementation Sales by Region: 2019-2024

3.2.2 Global Injectable Viscosupplementation Sales by Region: 2025-2030

3.3 Global Injectable Viscosupplementation Global Injectable Viscosupplementation Revenue by Region: 2019-2030

3.3.1 Global Injectable Viscosupplementation Revenue by Region: 2019-2024

3.3.2 Global Injectable Viscosupplementation Revenue by Region: 2025-2030

3.4 North America Injectable Viscosupplementation Market Facts & Figures by Country

3.4.1 North America Injectable Viscosupplementation Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Injectable Viscosupplementation Sales by Country (2019-2030)

3.4.3 North America Injectable Viscosupplementation Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Injectable Viscosupplementation Market Facts & Figures by Country

3.5.1 Europe Injectable Viscosupplementation Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Injectable Viscosupplementation Sales by Country (2019-2030)

3.5.3 Europe Injectable Viscosupplementation Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Injectable Viscosupplementation Market Facts & Figures by Country

3.6.1 Asia Pacific Injectable Viscosupplementation Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Injectable Viscosupplementation Sales by Country (2019-2030)

3.6.3 Asia Pacific Injectable Viscosupplementation Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Injectable Viscosupplementation Market Facts & Figures by Country

3.7.1 Latin America Injectable Viscosupplementation Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Injectable Viscosupplementation Sales by Country (2019-2030)

3.7.3 Latin America Injectable Viscosupplementation Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Injectable Viscosupplementation Market Facts & Figures by Country

3.8.1 Middle East and Africa Injectable Viscosupplementation Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Injectable Viscosupplementation Sales by Country (2019-2030)

3.8.3 Middle East and Africa Injectable Viscosupplementation Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Injectable Viscosupplementation Sales by Type (2019-2030)

4.1.1 Global Injectable Viscosupplementation Sales by Type (2019-2024)

4.1.2 Global Injectable Viscosupplementation Sales by Type (2025-2030)

4.1.3 Global Injectable Viscosupplementation Sales Market Share by Type (2019-2030)

4.2 Global Injectable Viscosupplementation Revenue by Type (2019-2030)

4.2.1 Global Injectable Viscosupplementation Revenue by Type (2019-2024)

4.2.2 Global Injectable Viscosupplementation Revenue by Type (2025-2030)

4.2.3 Global Injectable Viscosupplementation Revenue Market Share by Type (2019-2030)

4.3 Global Injectable Viscosupplementation Price by Type (2019-2030)

5 Segment by Application

5.1 Global Injectable Viscosupplementation Sales by Application (2019-2030)

5.1.1 Global Injectable Viscosupplementation Sales by Application (2019-2024)

5.1.2 Global Injectable Viscosupplementation Sales by Application (2025-2030)

5.1.3 Global Injectable Viscosupplementation Sales Market Share by Application (2019-2030)

5.2 Global Injectable Viscosupplementation Revenue by Application (2019-2030)

5.2.1 Global Injectable Viscosupplementation Revenue by Application (2019-2024)

5.2.2 Global Injectable Viscosupplementation Revenue by Application (2025-2030)

5.2.3 Global Injectable Viscosupplementation Revenue Market Share by Application (2019-2030)

5.3 Global Injectable Viscosupplementation Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Sanofi

6.1.1 Sanofi Corporation Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi Injectable Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Sanofi Injectable Viscosupplementation Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 Anika Therapeutics

6.2.1 Anika Therapeutics Corporation Information

6.2.2 Anika Therapeutics Description and Business Overview

6.2.3 Anika Therapeutics Injectable Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Anika Therapeutics Injectable Viscosupplementation Product Portfolio

6.2.5 Anika Therapeutics Recent Developments/Updates

6.3 Seikagaku

6.3.1 Seikagaku Corporation Information

6.3.2 Seikagaku Description and Business Overview

6.3.3 Seikagaku Injectable Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Seikagaku Injectable Viscosupplementation Product Portfolio

6.3.5 Seikagaku Recent Developments/Updates

6.4 Zimmer Biomet

6.4.1 Zimmer Biomet Corporation Information

6.4.2 Zimmer Biomet Description and Business Overview

6.4.3 Zimmer Biomet Injectable Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Zimmer Biomet Injectable Viscosupplementation Product Portfolio

6.4.5 Zimmer Biomet Recent Developments/Updates

6.5 Bioventus

6.5.1 Bioventus Corporation Information

6.5.2 Bioventus Description and Business Overview

6.5.3 Bioventus Injectable Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Bioventus Injectable Viscosupplementation Product Portfolio

6.5.5 Bioventus Recent Developments/Updates

6.6 Ferring

6.6.1 Ferring Corporation Information

6.6.2 Ferring Description and Business Overview

6.6.3 Ferring Injectable Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Ferring Injectable Viscosupplementation Product Portfolio

6.6.5 Ferring Recent Developments/Updates

6.7 LG Chem

6.6.1 LG Chem Corporation Information

6.6.2 LG Chem Description and Business Overview

6.6.3 LG Chem Injectable Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)

6.4.4 LG Chem Injectable Viscosupplementation Product Portfolio

6.7.5 LG Chem Recent Developments/Updates

6.8 Freda

6.8.1 Freda Corporation Information

6.8.2 Freda Description and Business Overview

6.8.3 Freda Injectable Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Freda Injectable Viscosupplementation Product Portfolio

6.8.5 Freda Recent Developments/Updates

6.9 Haohai Biological

6.9.1 Haohai Biological Corporation Information

6.9.2 Haohai Biological Description and Business Overview

6.9.3 Haohai Biological Injectable Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Haohai Biological Injectable Viscosupplementation Product Portfolio

6.9.5 Haohai Biological Recent Developments/Updates

6.10 Shanghai Jingfeng

6.10.1 Shanghai Jingfeng Corporation Information

6.10.2 Shanghai Jingfeng Description and Business Overview

6.10.3 Shanghai Jingfeng Injectable Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Shanghai Jingfeng Injectable Viscosupplementation Product Portfolio

6.10.5 Shanghai Jingfeng Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Injectable Viscosupplementation Industry Chain Analysis

7.2 Injectable Viscosupplementation Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Injectable Viscosupplementation Production Mode & Process

7.4 Injectable Viscosupplementation Sales and Marketing

7.4.1 Injectable Viscosupplementation Sales Channels

7.4.2 Injectable Viscosupplementation Distributors

7.5 Injectable Viscosupplementation Customers

8 Injectable Viscosupplementation Market Dynamics

8.1 Injectable Viscosupplementation Industry Trends

8.2 Injectable Viscosupplementation Market Drivers

8.3 Injectable Viscosupplementation Market Challenges

8.4 Injectable Viscosupplementation Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Injectable Viscosupplementation Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Injectable Viscosupplementation Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Injectable Viscosupplementation Market Competitive Situation by Manufacturers in 2023

Table 4. Global Injectable Viscosupplementation Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Injectable Viscosupplementation Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Injectable Viscosupplementation Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Injectable Viscosupplementation Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Injectable Viscosupplementation Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Injectable Viscosupplementation, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Injectable Viscosupplementation, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Injectable Viscosupplementation, Product Type & Application

Table 12. Global Key Manufacturers of Injectable Viscosupplementation, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Injectable Viscosupplementation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Viscosupplementation as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Injectable Viscosupplementation Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Injectable Viscosupplementation Sales by Region (2019-2024) & (K Units)

Table 18. Global Injectable Viscosupplementation Sales Market Share by Region (2019-2024)

Table 19. Global Injectable Viscosupplementation Sales by Region (2025-2030) & (K Units)

Table 20. Global Injectable Viscosupplementation Sales Market Share by Region (2025-2030)

Table 21. Global Injectable Viscosupplementation Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Injectable Viscosupplementation Revenue Market Share by Region (2019-2024)

Table 23. Global Injectable Viscosupplementation Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Injectable Viscosupplementation Revenue Market Share by Region (2025-2030)

Table 25. North America Injectable Viscosupplementation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Injectable Viscosupplementation Sales by Country (2019-2024) & (K Units)

Table 27. North America Injectable Viscosupplementation Sales by Country (2025-2030) & (K Units)

Table 28. North America Injectable Viscosupplementation Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Injectable Viscosupplementation Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Injectable Viscosupplementation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Injectable Viscosupplementation Sales by Country (2019-2024) & (K Units)

Table 32. Europe Injectable Viscosupplementation Sales by Country (2025-2030) & (K Units)

Table 33. Europe Injectable Viscosupplementation Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Injectable Viscosupplementation Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Injectable Viscosupplementation Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Injectable Viscosupplementation Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Injectable Viscosupplementation Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Injectable Viscosupplementation Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Injectable Viscosupplementation Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Injectable Viscosupplementation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Injectable Viscosupplementation Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Injectable Viscosupplementation Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Injectable Viscosupplementation Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Injectable Viscosupplementation Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Injectable Viscosupplementation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Injectable Viscosupplementation Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Injectable Viscosupplementation Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Injectable Viscosupplementation Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Injectable Viscosupplementation Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Injectable Viscosupplementation Sales (K Units) by Type (2019-2024)

Table 51. Global Injectable Viscosupplementation Sales (K Units) by Type (2025-2030)

Table 52. Global Injectable Viscosupplementation Sales Market Share by Type (2019-2024)

Table 53. Global Injectable Viscosupplementation Sales Market Share by Type (2025-2030)

Table 54. Global Injectable Viscosupplementation Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Injectable Viscosupplementation Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Injectable Viscosupplementation Revenue Market Share by Type (2019-2024)

Table 57. Global Injectable Viscosupplementation Revenue Market Share by Type (2025-2030)

Table 58. Global Injectable Viscosupplementation Price (US$/Unit) by Type (2019-2024)

Table 59. Global Injectable Viscosupplementation Price (US$/Unit) by Type (2025-2030)

Table 60. Global Injectable Viscosupplementation Sales (K Units) by Application (2019-2024)

Table 61. Global Injectable Viscosupplementation Sales (K Units) by Application (2025-2030)

Table 62. Global Injectable Viscosupplementation Sales Market Share by Application (2019-2024)

Table 63. Global Injectable Viscosupplementation Sales Market Share by Application (2025-2030)

Table 64. Global Injectable Viscosupplementation Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Injectable Viscosupplementation Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Injectable Viscosupplementation Revenue Market Share by Application (2019-2024)

Table 67. Global Injectable Viscosupplementation Revenue Market Share by Application (2025-2030)

Table 68. Global Injectable Viscosupplementation Price (US$/Unit) by Application (2019-2024)

Table 69. Global Injectable Viscosupplementation Price (US$/Unit) by Application (2025-2030)

Table 70. Sanofi Corporation Information

Table 71. Sanofi Description and Business Overview

Table 72. Sanofi Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Sanofi Injectable Viscosupplementation Product

Table 74. Sanofi Recent Developments/Updates

Table 75. Anika Therapeutics Corporation Information

Table 76. Anika Therapeutics Description and Business Overview

Table 77. Anika Therapeutics Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Anika Therapeutics Injectable Viscosupplementation Product

Table 79. Anika Therapeutics Recent Developments/Updates

Table 80. Seikagaku Corporation Information

Table 81. Seikagaku Description and Business Overview

Table 82. Seikagaku Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Seikagaku Injectable Viscosupplementation Product

Table 84. Seikagaku Recent Developments/Updates

Table 85. Zimmer Biomet Corporation Information

Table 86. Zimmer Biomet Description and Business Overview

Table 87. Zimmer Biomet Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Zimmer Biomet Injectable Viscosupplementation Product

Table 89. Zimmer Biomet Recent Developments/Updates

Table 90. Bioventus Corporation Information

Table 91. Bioventus Description and Business Overview

Table 92. Bioventus Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Bioventus Injectable Viscosupplementation Product

Table 94. Bioventus Recent Developments/Updates

Table 95. Ferring Corporation Information

Table 96. Ferring Description and Business Overview

Table 97. Ferring Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Ferring Injectable Viscosupplementation Product

Table 99. Ferring Recent Developments/Updates

Table 100. LG Chem Corporation Information

Table 101. LG Chem Description and Business Overview

Table 102. LG Chem Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. LG Chem Injectable Viscosupplementation Product

Table 104. LG Chem Recent Developments/Updates

Table 105. Freda Corporation Information

Table 106. Freda Description and Business Overview

Table 107. Freda Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Freda Injectable Viscosupplementation Product

Table 109. Freda Recent Developments/Updates

Table 110. Haohai Biological Corporation Information

Table 111. Haohai Biological Description and Business Overview

Table 112. Haohai Biological Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Haohai Biological Injectable Viscosupplementation Product

Table 114. Haohai Biological Recent Developments/Updates

Table 115. Shanghai Jingfeng Corporation Information

Table 116. Shanghai Jingfeng Description and Business Overview

Table 117. Shanghai Jingfeng Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Shanghai Jingfeng Injectable Viscosupplementation Product

Table 119. Shanghai Jingfeng Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Injectable Viscosupplementation Distributors List

Table 123. Injectable Viscosupplementation Customers List

Table 124. Injectable Viscosupplementation Market Trends

Table 125. Injectable Viscosupplementation Market Drivers

Table 126. Injectable Viscosupplementation Market Challenges

Table 127. Injectable Viscosupplementation Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Injectable Viscosupplementation

Figure 2. Global Injectable Viscosupplementation Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Injectable Viscosupplementation Market Share by Type in 2023 & 2030

Figure 4. Single Injection Product Picture

Figure 5. Three Injection Product Picture

Figure 6. Five Injection Product Picture

Figure 7. Global Injectable Viscosupplementation Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Injectable Viscosupplementation Market Share by Application in 2023 & 2030

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Other

Figure 12. Global Injectable Viscosupplementation Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Injectable Viscosupplementation Market Size (2019-2030) & (US$ Million)

Figure 14. Global Injectable Viscosupplementation Sales (2019-2030) & (K Units)

Figure 15. Global Injectable Viscosupplementation Average Price (US$/Unit) & (2019-2030)

Figure 16. Injectable Viscosupplementation Report Years Considered

Figure 17. Injectable Viscosupplementation Sales Share by Manufacturers in 2023

Figure 18. Global Injectable Viscosupplementation Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Injectable Viscosupplementation Players: Market Share by Revenue in 2023

Figure 20. Injectable Viscosupplementation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Injectable Viscosupplementation Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Injectable Viscosupplementation Sales Market Share by Country (2019-2030)

Figure 23. North America Injectable Viscosupplementation Revenue Market Share by Country (2019-2030)

Figure 24. United States Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Injectable Viscosupplementation Sales Market Share by Country (2019-2030)

Figure 27. Europe Injectable Viscosupplementation Revenue Market Share by Country (2019-2030)

Figure 28. Germany Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Injectable Viscosupplementation Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Injectable Viscosupplementation Revenue Market Share by Region (2019-2030)

Figure 35. China Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Injectable Viscosupplementation Sales Market Share by Country (2019-2030)

Figure 45. Latin America Injectable Viscosupplementation Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Injectable Viscosupplementation Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Injectable Viscosupplementation Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Injectable Viscosupplementation Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Injectable Viscosupplementation by Type (2019-2030)

Figure 55. Global Revenue Market Share of Injectable Viscosupplementation by Type (2019-2030)

Figure 56. Global Injectable Viscosupplementation Price (US$/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Injectable Viscosupplementation by Application (2019-2030)

Figure 58. Global Revenue Market Share of Injectable Viscosupplementation by Application (2019-2030)

Figure 59. Global Injectable Viscosupplementation Price (US$/Unit) by Application (2019-2030)

Figure 60. Injectable Viscosupplementation Value Chain

Figure 61. Injectable Viscosupplementation Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Cell Harvesting Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10F1858

Mon May 20 00:00:00 UTC 2024

Add to Cart

Global Hybrid OR Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6D6308

Mon May 20 00:00:00 UTC 2024

Add to Cart

Global Dental Syringes Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-18T8774

Mon May 20 00:00:00 UTC 2024

Add to Cart

Global Hospital Mobile Carts Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34B1976

Mon May 20 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions